Lead Plaintiff Deadline is October 27, 2025
NEW YORK, Sept. 03, 2025 (GLOBE NEWSWIRE) — Wolf Haldenstein Adler Freeman & Herz LLP is notifying investors about a federal securities class action lawsuit against LifeMD, Inc. (NASDAQ: LFMD) (“LifeMD” or the “Company”).
PLEASE CLICK HERE TO JOIN THE CASE AND SUBMIT CONTACT INFORMATION
LifeMD, Inc. (NASDAQ: LFMD) Securities Class Action Lawsuit
- Class Period: May 7, 2025 – August 5, 2025
- Lead Plaintiff Deadline: October 27, 2025
- Court: United States District Court for the Eastern District of New York
Allegations
The complaint alleges that LifeMD and its executives violated federal securities laws by making false and/or misleading statements and/or failing to disclose that:
1. LifeMD materially overstated its competitive position.
2. The Company was reckless in raising 2025 guidance, failing to account for:
- Rising customer acquisition costs in its RexMD segment, and
- Costs related to acquiring customers for obesity drugs such as Wegovy and Zepbound.
3. As a result, statements about LifeMD’s business, operations, and prospects were materially false, misleading, and/or lacked a reasonable basis.
Corrective Disclosure
-
August 5, 2025 (after market close):
LifeMD reported Q2 2025 financial results and revised guidance:- New revenue outlook: $250 – $255 million
- Prior guidance: $268 – $275 million
- Market Reaction: On August 6, 2025, LifeMD’s stock price plummeted 44.8%.
Next Steps for Investors:
- Investors who suffered losses can seek appointment as lead plaintiff prior to October 27, 2025 by contacting Wolf Haldenstein.
Why Wolf Haldenstein Adler Freeman & Herz LLP?:
This illustrious firm, founded in 1888, is steadfast in their pursuit of justice for investors who have suffered financial harm due to these misrepresented statements. The law firm brings to the fore over 125 years of legal expertise in securities litigation and has a proven track record of protecting the rights of investors.
We encourage all investors who have been affected or have information that will assist in our investigation, to contact Wolf Haldenstein Adler Freeman & Herz LLP.
Contact:
- Phone: (800) 575-0735 or (212) 545-4774
-
Email:
[email protected] - Contact Person: Gregory Stone, Director of Case and Financial Analysis
Firm Website:
Wolf Haldenstein Adler Freeman & Herz LLP
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.
